This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Andrea K Myers: Innovator in Hydroxylase Inhibitors
Introduction
Andrea K Myers is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of hydroxylase inhibitors. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.
Latest Patents
Among her latest patents are the N-substituted glycine derivatives, which serve as hydroxylase inhibitors. The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I). These compounds act as antagonists of HIF prolyl hydroxylases and are useful for treating diseases that benefit from the inhibition of this enzyme, with anemia being one example.
Career Highlights
Andrea has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Throughout her career, Andrea has collaborated with notable professionals in her field, including Antony N Shaw and Kevin J Duffy. These collaborations have likely enriched her research and development efforts.
Conclusion
Andrea K Myers is a distinguished inventor whose work in hydroxylase inhibitors showcases her commitment to advancing medical science. Her contributions are poised to make a significant difference in the treatment of diseases like anemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile